SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Fundamental Analysis
FRA:56S1 - FR0013154002 - Common Stock
177.25 EUR
+1.5 (+0.85%)
Taking everything into account, 56S1 scores 5 out of 10 in our fundamental rating. 56S1 was compared to 18 industry peers in the Life Sciences Tools & Services industry. 56S1 has an average financial health and profitability rating. 56S1 shows excellent growth, but is valued quite expensive already. With these ratings, 56S1 could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
In the past year 56S1 was profitable.
In the past year 56S1 had a positive cash flow from operations.
Each year in the past 5 years 56S1 has been profitable.
In the past 5 years 56S1 always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 2.71%, 56S1 is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
56S1's Return On Equity of 5.63% is in line compared to the rest of the industry. 56S1 outperforms 44.44% of its industry peers.
With a Return On Invested Capital value of 4.60%, 56S1 perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
56S1 had an Average Return On Invested Capital over the past 3 years of 10.41%. This is above the industry average of 7.23%.
The last Return On Invested Capital (4.60%) for 56S1 is well below the 3 year average (10.41%), which needs to be investigated, but indicates that 56S1 had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 5.63% | ||
| ROIC | 4.6% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
1.3 Margins
56S1's Profit Margin of 7.78% is fine compared to the rest of the industry. 56S1 outperforms 61.11% of its industry peers.
In the last couple of years the Profit Margin of 56S1 has declined.
The Operating Margin of 56S1 (14.71%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of 56S1 has declined.
The Gross Margin of 56S1 (44.63%) is better than 66.67% of its industry peers.
In the last couple of years the Gross Margin of 56S1 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.71% | ||
| PM (TTM) | 7.78% | ||
| GM | 44.63% |
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 56S1 is creating some value.
56S1 has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 56S1 has more shares outstanding
56S1 has a better debt/assets ratio than last year.
2.2 Solvency
56S1 has an Altman-Z score of 3.72. This indicates that 56S1 is financially healthy and has little risk of bankruptcy at the moment.
56S1 has a Altman-Z score of 3.72. This is amongst the best in the industry. 56S1 outperforms 83.33% of its industry peers.
The Debt to FCF ratio of 56S1 is 5.98, which is a neutral value as it means it would take 56S1, 5.98 years of fcf income to pay off all of its debts.
56S1 has a Debt to FCF ratio (5.98) which is in line with its industry peers.
A Debt/Equity ratio of 0.71 indicates that 56S1 is somewhat dependend on debt financing.
The Debt to Equity ratio of 56S1 (0.71) is worse than 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.98 | ||
| Altman-Z | 3.72 |
ROIC/WACC0.54
WACC8.45%
2.3 Liquidity
A Current Ratio of 1.91 indicates that 56S1 should not have too much problems paying its short term obligations.
56S1 has a better Current ratio (1.91) than 83.33% of its industry peers.
A Quick Ratio of 1.18 indicates that 56S1 should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.18, 56S1 is doing worse than 61.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
56S1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.91%, which is quite impressive.
56S1 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.19% yearly.
The Revenue has been growing slightly by 5.44% in the past year.
The Revenue has been growing by 14.05% on average over the past years. This is quite good.
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%
3.2 Future
The Earnings Per Share is expected to grow by 22.34% on average over the next years. This is a very strong growth
Based on estimates for the next years, 56S1 will show a quite strong growth in Revenue. The Revenue will grow by 10.54% on average per year.
EPS Next Y27.61%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
EPS Next 5Y22.34%
Revenue Next Year9.1%
Revenue Next 2Y9.69%
Revenue Next 3Y10.4%
Revenue Next 5Y10.54%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 42.92, the valuation of 56S1 can be described as expensive.
72.22% of the companies in the same industry are cheaper than 56S1, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of 56S1 to the average of the S&P500 Index (27.06), we can say 56S1 is valued expensively.
A Price/Forward Earnings ratio of 33.03 indicates a quite expensive valuation of 56S1.
Based on the Price/Forward Earnings ratio, 56S1 is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of 56S1 to the average of the S&P500 Index (22.69), we can say 56S1 is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.92 | ||
| Fwd PE | 33.03 |
4.2 Price Multiples
56S1's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 56S1 is more expensive than 77.78% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 56S1 is valued a bit more expensive than 61.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.75 | ||
| EV/EBITDA | 26.32 |
4.3 Compensation for Growth
56S1's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as 56S1's earnings are expected to grow with 23.30% in the coming years.
PEG (NY)1.55
PEG (5Y)10.23
EPS Next 2Y23.83%
EPS Next 3Y23.3%
5. Dividend
5.1 Amount
With a yearly dividend of 0.40%, 56S1 is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.73, 56S1 has a dividend in line with its industry peers.
With a Dividend Yield of 0.40, 56S1 pays less dividend than the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
5.2 History
The dividend of 56S1 has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
56S1 pays out 29.77% of its income as dividend. This is a sustainable payout ratio.
The dividend of 56S1 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP29.77%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
FRA:56S1 (9/1/2025, 7:00:00 PM)
177.25
+1.5 (+0.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners10.65%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.25B
Analysts81.11
Price Target238.51 (34.56%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP29.77%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.2%
Min EPS beat(2)10.22%
Max EPS beat(2)22.18%
EPS beat(4)3
Avg EPS beat(4)8.6%
Min EPS beat(4)-5.62%
Max EPS beat(4)22.18%
EPS beat(8)3
Avg EPS beat(8)-10.02%
EPS beat(12)3
Avg EPS beat(12)-13.27%
EPS beat(16)5
Avg EPS beat(16)-12.35%
Revenue beat(2)2
Avg Revenue beat(2)1.91%
Min Revenue beat(2)0.3%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)3.52%
Revenue beat(8)5
Avg Revenue beat(8)-0.72%
Revenue beat(12)5
Avg Revenue beat(12)-1.47%
Revenue beat(16)8
Avg Revenue beat(16)12%
PT rev (1m)-1.79%
PT rev (3m)-3.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.26%
EPS NY rev (1m)2.93%
EPS NY rev (3m)2.93%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-0.9%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)0.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.92 | ||
| Fwd PE | 33.03 | ||
| P/S | 5.96 | ||
| P/FCF | 34.75 | ||
| P/OCF | 21.89 | ||
| P/B | 4.31 | ||
| P/tB | N/A | ||
| EV/EBITDA | 26.32 |
EPS(TTM)4.13
EY2.33%
EPS(NY)5.37
Fwd EY3.03%
FCF(TTM)5.1
FCFY2.88%
OCF(TTM)8.1
OCFY4.57%
SpS29.76
BVpS41.13
TBVpS-4.66
PEG (NY)1.55
PEG (5Y)10.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 5.63% | ||
| ROCE | 5.78% | ||
| ROIC | 4.6% | ||
| ROICexc | 5.12% | ||
| ROICexgc | 15.67% | ||
| OM | 14.71% | ||
| PM (TTM) | 7.78% | ||
| GM | 44.63% | ||
| FCFM | 17.14% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexcg growth 3Y-36.77%
ROICexcg growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.98 | ||
| Debt/EBITDA | 3.84 | ||
| Cap/Depr | 93.43% | ||
| Cap/Sales | 10.07% | ||
| Interest Coverage | 2.82 | ||
| Cash Conversion | 106.77% | ||
| Profit Quality | 220.28% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 3.72 |
F-Score7
WACC8.45%
ROIC/WACC0.54
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
EPS Next Y27.61%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
EPS Next 5Y22.34%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%
Revenue Next Year9.1%
Revenue Next 2Y9.69%
Revenue Next 3Y10.4%
Revenue Next 5Y10.54%
EBIT growth 1Y7.47%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year91.76%
EBIT Next 3Y37.04%
EBIT Next 5Y27.81%
FCF growth 1Y202.01%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y16.41%
OCF growth 3Y5.11%
OCF growth 5Y21.32%